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Hematopoietic stem cells (HSCs) reside in bone marrow niches and give rise to hematopoietic precursor cells (HPCs). These
have more restricted lineage potential and eventually differentiate into specific blood cell types. Bone marrow also contains
mesenchymal stromal cells (MSCs), which present multilineage differentiation potential toward mesodermal cell types. In bone
marrow niches, stem cell interaction with the extracellular matrix is mediated by integrin receptors. Ion channels regulate cell
proliferation and differentiation by controlling intracellular Ca2+, cell volume, release of growth factors, and so forth. Although
little evidence is available about the ion channel roles in true HSCs, increasing information is available about HPCs and MSCs,
which present a complex pattern of K+ channel expression. K+ channels cooperate with Ca2+ and Cl− channels in regulating
calcium entry and cell volume during mitosis. Other K+ channels modulate the integrin-dependent interaction between leukemic
progenitor cells and the niche stroma. These channels can also regulate leukemia cell interaction with MSCs, which also involves
integrin receptors and affects the MSC-mediated protection from chemotherapy. Ligand-gated channels are also implicated
in these processes. Nicotinic acetylcholine receptors regulate cell proliferation and migration in HSCs and MSCs and may be
implicated in the harmful effects of smoking.
1. Introduction
In early embryos, totipotent blastomeres are defined as cells
able to produce every cell type of the adult organism. During
development, a progressive restriction in differentiation
potency occurs, with primordial pluripotent cells being able
to yield other stem cells (self-renewal) and originate all
cell lineages except the extraembryonic ones [1]. Further
restriction is observed in adult tissues, in which cell lineages
comprise slowly dividing stem cells. These, besides self-
renewing, divide to generate transit amplifying cells which
undergo many mitotic cycles before differentiating into the
tissue cell types. For example, neural stem cells, located in
restricted regions of the brain, can differentiate into neurons,
astrocytes, and oligodendrocytes. Whether the spectrum
of possible differentiation outcomes depends on extrinsic
regulation or is founded on the existence of heterogeneous
stem cell populations is uncertain [2]. A similar pattern is
thought to exist in cancer tissue, in which a few stem cells
maintain the neoplastic cell population, whereas themajority
of cells composing the tumor rapidly divide and display only
limited self-renewal properties [3].
The contribution of ion channels and transporters to
the regulation of cell proliferation and differentiation is
increasingly recognized. The field has greatly expanded in
the last ten years and cannot be fully discussed here. The
reader is referred to several recent reviews that cover themain
aspects and provide introduction to specialized literature
[4–11]. Although the precise mechanisms are still debated,
evidence exists about the involvement of both voltage-gated
and ligand-gated channels. As a first approximation, the
well-known correlation between depolarization and prolif-
eration seems to hold in embryonic stem cells. For exam-
ple, inhibition of KCNQ1 potassium channels by altered
expression of the accessory β subunit XKCNE1 depolarizes
neural crest cells in Xenopus. This effect is accompanied by
hyperproliferation [12]. Conversely, paracrine stimulation of
GABAA receptors, which tends to hyperpolarize embryonic
stem cells and peripheral neural crest stem cells in mice, is
accompanied by inhibition of cell proliferation [13].
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A cell’s decision to divide or differentiate is regulated by
both intracellular molecular cascades and local environmen-
tal cues. Ion channels appear often to behave as signaling piv-
ots that coordinate these upstream and downstream signals.
By governing membrane potential (Vm) and transmembrane
calcium flux, ion channels regulate the calcium signals that
punctuate the mitotic cycle as well as processes such as
neurite extension and exocytosis of autocrine or angiogenetic
factors [8]. Moreover, transmembrane ion fluxes drive the
cell volume oscillations typical of cycling and migrating cells
[14, 15]. However, these examples certainly do not exhaust
the range of ion channel functions in cell proliferation
and differentiation and other regulatory roles may or may
not depend on ion transport. For instance, the channel
proteins can form macromolecular complexes with growth
factor receptors, cell adhesion receptors and related proteins
[16–19]. These mechanisms have been especially studied in
mature and immature blood cells [16, 19, 20], and their
alteration can promote neoplastic invasiveness. Because of
such complexity, a simple comprehensive picture of the
physiology of ion channels in cell cycle and differentiation
is not available and probably cannot be reached. In the
following, we discuss some of these issues as related to
the hematopoietic system. Since relatively few studies have
addressed ion channel physiology in adult and embryonic
stem cells, we believe an ample and potentially fruitful field
is offered to future research.
2. Hematopoietic and Mesenchymal
Stem Cells: The Fundamentals
Hematopoiesis allows the lifelong turnover of blood cells.
In adult mammals, small populations of hematopoietic
stem cells (HSCs) reside in the bone marrow (BM). HSCs
originate hematopoietic precursor cells (HPCs) with more
restricted lineage potential, which eventually differentiate
into specific blood cells. Permanence of a functional HSC
population throughout life is guaranteed by stem cell self-
renewal as well as HSC dwelling in protected BM niches, in
which 90–95% of HSCs are maintained in a quiescent state
[21, 22]. The exact proportions of different cell populations
and the rate of cell cycle entry vary in rodents and humans
[23]. Adult quiescent HSCs arise from actively proliferating
fetal HSC [24]. These are first located in placenta and aorta-
gonad-mesonephros, which are subsequently substituted by
the fetal liver. Fetal HSCs initially rapidly produce red
blood cells and in a second phase generate all blood
cell lineages plus engrafting HSCs [21, 25]. These latter
actively proliferate during development bymainly generating
erythroid andmyeloid lineages, to produce the blood system.
In rodents, HSCs colonize BM between embryonic day 17
and postnatal day 14. Subsequently, they remain anchored to
the BM niche by integrin-dependent mechanisms [26, 27].
The BM stroma is constituted by stromal cells (fibrob-
lasts, endothelial cells, macrophages, and osteoblasts) and
extracellular matrix proteins. Stroma contributes to regu-
late hematopoiesis through signals triggered by adhesion-
dependent and soluble factors. In the adult, HSCs and
HPCs mostly reside in BM, whereas they actively migrate
between the hematopoietic tissues during fetal development.
Integrins exert a central regulatory role, as they mediate
most of the functional interactions between hematopoietic
cells and the bone marrow microenvironment [26–28]. The
regulated expression of specific integrin subunits and their
localization in selected areas of the BM confirm that these
molecules exert a variety of functions in hematopoiesis [26].
The expression of cell-matrix and cell-cell adhesion receptors
in HSCs and HPCs has been extensively reviewed elsewhere
[20].
Mesenchymal stromal cells (MSCs), formerly known
as mesenchymal stem cells, are adult stem cells originally
isolated from BM. Subsequent studies have shown that
MSCs are stromal progenitors also found in other adult
tissues. They are endowed with multilineage differentiation
potential toward mesodermal cell lineages and extensive
immunomodulatory properties. MSCs actively proliferate in
some tissues, but remain quiescent in others [29]. Three
main criteria have been identified by the International
Society of Cellular Therapy to define MSCs: (i) adhesion to
plastic, (ii) expression of specific immunophenotypic marker
combinations (CD73, CD90, and CD105), accompanied
by lack of expression of hematopoietic markers (CD14,
CD34, and CD45) and class II major histocompatibility
complex (MHC) molecules; (iii) capability of differentiat-
ing into mesodermal lineages (adipocytes, cardiomyocytes,
osteoblasts, and chondrocytes) [30, 31]. All cultured MSCs
tend to present these features, although some differences
are observed among the MSCs from a given tissue such as
expression of surface CD34 and CD54 in MSCs derived from
adipose tissue. In addition, MSCs may show in vitro, under
specific experimental conditions, some features of differen-
tiation into tissues of endodermal and neuroectodermal lin-
eages, such as hepatocytes, epithelia, and neurons, although
their genuine differentiation into nonmesodermal cells is still
matter of debate [31]. Because of their properties, MSCs have
drawn considerable interest as potentially useful material for
tissue engineering and cell-based therapy. Human BM is now
the major MSC source for both experimental and clinical
studies [32–36].
3. Ion Channels in HSCs and HPCs
3.1. K+ Channels and Other Channels Related to the Voltage-
Gated Superfamily. To the best of our knowledge, no studies
have been published about the K+ channel expression in bona
fide HSCs. However, inward rectifying K+ currents (KIR)
have been measured in primitive HPCs (CD34+ CD38−),
after stimulation with interleukin-3 (IL-3) plus stem cell
factor (SCF [37]). The term inward rectifier applies to
those ion channels that tend to be more permeable to
ions flowing toward the cytoplasm. However, it should be
remembered that not all channels known to belong to
the KIR structural family (Kir subunits) display prominent
inward rectification. Interestingly, measurements in HPCs
showed expression of both strongly rectifying (Kir4.3) and
weakly rectifying (Kir1.1) K+ channels. Evidence that this
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is necessary to generate committed progenitors in vitro
was obtained in umbilical cord blood CD34+ CD38−
cells, in which inhibiting either channel type suppresses
the generation of progenitor cells stimulated by IL-3- and
SCF [38]. These observation are consistent with the notion
that different K+ channel types give distinct contributions
to proliferation and differentiation. In general, the strong
inward rectifiers and the background channels K2P (two-
pore domain K+ channels) seem to be mainly responsible
to regulate the resting Vm. In immature B cells, Nam et al.
[39] recently identified two kinds of K2P channels, namely,
TREK-2 (TWIK-related K+ channel type 2) and TASK-2
(TWIK-related acid-sensitive K+ channel type 2). TASK-2 is
activated by stimulation of B cells receptors (BCRs ligation)
and participates in the BCR-ligation-dependent apoptosis
[39]. Other types of K+ channel are thought to cooperate
with the other membrane transport systems to regulate cell
volume, secretion of paracrine factors, calcium influx, and
so forth. These processes may be accompanied by oscillations
in Vm, cell volume, and intracellular calcium [8]. The whole
picture can thus be very complex, as is now made clear
by extensive expression studies. In CD34+/CD45+/CD133high
cells from peripheral blood [40], RT-PCR showed expression
of KV1.3, KV7.1, NaV1.7, TASK 2, TALK 2 (TWIK-related
alkaline pH-activated K+ channel type 2), TWIK 2 (tandem
of pore domains in a weak inward rectifying K+ channel,
type 2), TRPC4, 6, TRPM2,7, and TRPV2 and patch-clamp
recordings identified voltage gated K+ currents, TASK 2-like
K+ currents, TRPM2 currents, and TRPC6-like currents [40].
Some voltage-dependent K+ channels, particularly
KV11.1 (also known as hERG1), are directly implicated
in regulating the integrin-dependent cell adhesion, which
is potentially important for cell physiology inside the BM
marrow niches [20, 41]. In leukemic osteoclastic progenitors,
hERG1 activates during cell adhesion to fibronectin. Channel
activation mediates a complex regulatory network that
control cell adhesion, as it increases expression of αVβ3
integrin (CD51 [42]). Moreover, hERG1 is upregulated
in leukemic hematopoietic cells [43, 44]. In particular,
the Kv11.1 transcript was detected in circulating CD34+
cells stimulated to proliferate by IL-3 (interleukin 3), SCF
(stem cell factor), GM-CSF (granulocyte-macrophage
colony-stimulating factor), and G-CSF (granulocyte colony-
stimulating factor [43]. In stimulated CD34+ cells, KV11.1
associates with β1 integrin, which is essential for proper
bone marrow engraftment of these HPCs [19]. The Kv11.1
transcript was also detected in CD34+/CD38−/CD123high
cells, which constitute the stem cell population critical for
perpetuating leukemia [45]. The involvement of KV11.1 in
the physiology of leukemic and stem cells is further discussed
in Section 4.4.
Overall, relatively ample evidence indicates that KV
channels are important modulators of normal and leukemic
HSCs. It is, however, clear that the physiological comprehen-
sion of these processes is still in its infancy.
3.2. Neuronal Nicotinic Receptors (nAChRs) and Hemato-
poiesis. The neuronal nicotinic acetylcholine receptors
(nAChRs) are ligand-gated pentameric ion channels that
mediate fast excitatory postsynaptic potentials as well as
slower paracrine actions of ACh. Growing evidence shows
that nAChRs are also widely expressed in nonnervous
tissue, including lymphocytes, and in cancer cells [46].
Since nicotine is a well-known risk factor for cancer, these
observations have stimulated work aimed to determine
whether and how nAChRs contribute to regulate the main
cellular events associated with neoplastic progression, that
is, cell proliferation and survival, invasiveness, the epithelial-
mesenchymal transition and angiogenesis [47]. The nAChRs
are homo- or hetero-pentamers of α (α2–α9) and β (β2–β4)
subunits, arranged with different possible stoichiometries,
characterized by different physiological and pharmacolog-
ical properties [46, 47]. Interestingly, recent genomewide
association studies attribute to the gene cluster coding for
the α3/α5/β4 nAChR subunits a role in both development
of lung cancer and nicotine addiction [48–50]. Many
cellular effects of nicotine-and tobacco-derived metabolites
are probably caused by nAChR activation, which leads to
increased cytosolic calcium. This can stimulate intracellular
pathways both directly as well as by increasing the release of
autocrine/paracrine factors [51–53]. Nonconductive signals
exerted by nAChRs have also been observed [54]. In general,
the precise function of nAChRs in normal and neoplastic
cells is difficult to determine because many cells express a
variety of nicotinic subunits, whose interplay is unclear [47].
In humans, smoking is associated with increased leuko-
cyte count [55–57]. Recent work in mice indicates that
treatment with nicotine increases leukocytes in peripheral
blood, BM, and spleen [58], in keeping with previous results
showing that nicotine stimulates hematopoiesis [59]. The
effect is correlated with higher frequency of HSCs in bone
marrow [58]. Long-term HSCs isolated from treated mice
appear to remain fully competent and express nAChRs, as
demonstrated by binding of α-bungarotoxin (specific for α7-
containing nAChRs and the muscle isoform). The expression
pattern of other nAChR subunits was not reported. Regard-
less, these results are consistent with the previous observation
that mice deficient of α7 display a reduction of myeloid
and erythroid lineages [60]. Although the mechanisms of
nAChR implication in these processes are unclear, these
studies suggest that the cholinergic system is implicated
in regulating hematopoiesis. From a pathologic standpoint,
some of the effects of prolonged tobacco use may thus be
caused by nAChR targeting. However, it should be kept in
mind that α7 receptors desensitize rapidly in the presence
of agonists. Therefore, to understand their physiological
role in hematopoiesis, it will be important to precisely
determine how these effects depend on the concentration of
nicotine and other tobacco-related compounds. Low doses
may sustain steady state nAChR currents, although with
low amplitude, whereas higher doses may produce strong
channel desensitization. In fact, the available evidence, albeit
fragmentary, indicates that high concentrations of nicotine
produce inhibition of hematopoiesis, instead of stimulation
[60]. Hence, it is possible that different smoking habits
produce opposite effects on hematopoiesis.
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4. Ion Channels in Mesenchymal Stem Cells
4.1. MSCs from BoneMarrow (BM-MSCs). Although human
MSCs have been used for several years in the investigation
of cell therapy and differentiation [36, 61, 62], a coherent
picture of the physiological functions of the different ion
channels expressed in these cells is not available. Not sur-
prisingly, most results concern human BM-MSCs. In these
cells, Kawano et al. first observed spontaneous inositol 1,4,5-
trisphosphate-dependent Ca2+ oscillations, which are regu-
lated by the Na+-Ca2+ exchanger and the plasma membrane
Ca2+ pump [63, 64]. For review of the calcium handling
system in MSCs, see [65]. In addition, approximately 10–
15% of BM-MSCs express the L-type calcium current (ICaL)
and related mRNAs such as α1C [34, 35, 66], although ICaL
does not seem to be significantly implicated in controlling
the spontaneous cell activity [66]. Nonetheless, the calcium
oscillations are completely blocked by removing extracellular
calcium and by applying La3+, while the intracellular stores
are not depleted. This suggests that an unknown pathway,
probably mediated by nonselective cation channels, controls
calcium entry in hMSC and contributes to sustain the [Ca2+]i
oscillations [64]. These latter drive the activity of high-
conductance Ca2+-dependent K+ channels (BKCa), which
in turn determines Vm cycling [64, 67]. In human BM-
MSCs, KCa currents and the corresponding MaxiK mRNA
were also observed by others, along with a slowly activating
K+ current distinct from the rapidly activating KCa [34].
Significant mRNA expression was also detected for KV1.4,
KV4.2, KV4.3, and HCN2, but no corresponding functional
currents were reported [34]. These were instead reported by
Li et al. [35] who, besides BKCa and ICaL, measured transient
outward voltage-dependent K+ channels sensitive to 4-
aminopyridine whose molecular correlates were identified
as KV1.4 and KV4.2 and denoted in the literature as IA or
ITO (for a brief summary of IK nomenclature, see [68]).
These authors also observed expression of KV10.1-delayed
rectifying K+ channels (also known as ether-a`-go-go type
1, EAG1), accompanied by the corresponding mRNA [35].
Finally, in hBM-MSCs, expression of KATP channels (Kir6.1
and Kir6.2) and the regulatory subunit SUR2A was detected
by RT-PCR and immunolabeling. Osteogenic differentiation
strongly increased Kir6.2, whereas adipogenic differentiation
reduced Kir6.1 and SUR2A [69].
Broadly speaking, the above pattern seems also to apply
to BM-MSCs prepared from rats [70–72] and mice [73,
74], where the effects on proliferation of modulating ion
channels have been studied in some more detail. Rat BM-
MSCs express both high- and intermediate-conductance KCa
(resp., slo or KCa1.1 and KCNN4 or KCa3.1), IKDR (KV1.2
and KV2.1), IA (KV1.4 and KV4.3), ICaL and TTX-sensitive
Na+ currents [70–72]. In these cells, KDR-decreased whereas
intermediate-conductance KCa3.1 increased during progres-
sion from G1 to S phase. Downregulating these channels
with specific interfering RNAs blocked cell proliferation [71].
The partial substitution of KDR with KCa during cell cycle
progression agrees with the model originally proposed in T
lymphocytes, in which sequential activation of KV and KCa
during mitosis triggers and sustains cell hyperpolarization,
with ensuing facilitation of Ca2+ entry and stimulation of
the cell cycle machinery [75]. In murine MSCs, the usual
KCa3.1 channel is accompanied by KIR currents (Kir2.1)
and volume-regulated Cl− channels (CLCN3 [73]). KCa and
Cl− channels cooperate in regulating cell proliferation by
modulating cyclin D1 and cyclin E expression [74]. KCa, ICaL,
and IA (KV1.4) were also observed in undifferentiated MSCs
isolated from chicken embryos [76].
As is often the case, some types of K+ channels are
involved in processes related to cell adhesion and migration.
For instance, Hu et al. [77] found that KV2.1 regulates
directed migration and homing of BM-MSCs. Hypoxic
preconditioning increases KV2.1 expression and enhances
the channel activity that subsequently augments phospho-
rylation/activation of the focal adhesion kinase and cell
migration, resulting in increased homing of transplanted
BM-MSCs to the injured region [77].
Finally, about 30% of human BM-MSC cells were found
to express TTX-sensitive voltage-gated Na+ currents [34].
This observation was also carried out in rodents [70, 73] and
chicken embryo MSCs [76], but its physiological meaning is
uncertain.
4.2. MSCs from Human Umbilical Cord Vein (hUC-MSCs).
The expression of ion channels has been recently studied in
undifferentiated hUC-MSCs [78]. Patch-clamp experiments
revealed iberiotoxin-sensitive IKCa, IA, and IDR currents.
Once again, about 30% of these cells express functional TTX-
sensitive Na+ currents, whereas no more than 5% of the cells
express KIR. The molecular correlates of these currents were
investigated by RT-PCR, which revealed the expression of
KV1.1, KV4.2, KV1.4, Kir2.1, heag1, MaxiK, hNE-Na, and
TWIK-1 [78]. Therefore, the overall pattern is similar to the
one shown by BM-derived cells.
4.3. MSCs Derived from Human-Induced Pluripotent Stem
Cells (iPSCs). iPSCs produce a high yield ofMSCs.Moreover
iPSC-derived MSCs present higher proliferation capacity
than BM-derived stem cells, thus providing a better option
for applications in regenerative medicine. Zhang et al. [79]
recently studied whether the different proliferative potential
of iPSC-MSCs may be founded on significant differences
in ion channel expression compared to BM-MSCs. Patch-
clamp measurements revealed five functional ion currents
in human iPSC-MSCs: BKCa, intermediate-conductance KCa,
KDR, KIR, and voltage-gated Cl− channels, whereas the
latter Cl− currents were not detected in BM-MSCs. RT-
PCR revealed significant expression in both cell types of
KCa1.1, KCa3.1, KV10.1, Kir2.1, SCN9A, CACNA1C, and
Clcn3. In contrast, Kir2.2 and Kir2.3 were only found in
iPSC-MSCs. Interestingly, the expression level of KV10.1 was
much higher in iPSC-MSCs than in BM-MSCs. In agreement
with the proliferative potential conferred by KV10.1 (hEAG1)
to different cell types [80], block of hEAG1 tended to inhibit
cell proliferation in both cell types. Consistently with the
expression pattern, the effect was more pronounced in iPSC-
MSCs.
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These observations may contribute to explain the greater
proliferative capacity of iPSC-MSCs, which may be corre-
lated with specific patterns of channel expression. In general,
the diversity of ion channel expression in MSCs might
reflect the existence of different cell populations. Differently
from immortalized cell lines, pure populations of MSCs
have been so far impossible to isolate. As discussed earlier,
identification of human MSCs is mainly based on their
plastic-adherence features in standard culture conditions and
expression or lack of expression of an ensemble of surface
markers. As has been observed in other cell types, some
channel types seem specifically implicated in controlling
cell cycle. Interestingly, evidence summarized in the above
sections also suggests that KIR currents tend to be expressed
in stem cells at earlier stages, that is, in cells with broader
differentiation potential. This may be different from what
has been observed in the nervous system, where for example,
KIR currents mark late stages of quail neural crest cell
differentiation [81].
4.4. KV11.1 (hERG1) Channels in Leukemic Cells Mediate
Cell Interaction with MSCs. BM-MSCs can protect leukemic
cells from chemotherapy by secreting the chemokine SDF-
1 (also known as CXCL11), which binds to the G-protein-
coupled receptor CXCR4 (chemokine receptor CXC 4 [82])
expressed onto leukemia cells [83]. Adhesion between these
cell types is consolidated by engagement of the integrin
receptors expressed onto leukemic cells, typically α5β1
(VLA-5) and α4β1 (VLA-4). These interact with extra-
cellular matrix proteins on the MSCs [84]. MSCs thus
regulate intracellular signaling cascades in leukemic cells that
lead to antiapoptotic effects, as shown in acute myeloid
leukemia [85], chronic lymphocytic leukemia [86–88], and
chronic myeloid leukemia [89]. These intracellular signals
are thought to require integrin-dependent activation of ILK
(integrin-linked kinase), with subsequent recruitment of
the MAPK and the phosphoinositide 3-kinase (PI3K)/Akt
pathways, at least in myeloid leukemia.
We recently studied the molecular mechanisms under-
lying the analogous effect observed in acute lymphoblastic
leukemia (ALL) cells [90]. Coculture of ALL cells with
MSCs induced on the lymphoblast plasma membrane the
expression of a signaling complex formed by hERG1, the
β1 integrin subunit, and CXCR4. Such complex is absent in
normal B lymphocytes. Moreover MSCs also do not express
hERG1. Assembly of the protein complex activated the
prosurvival pathways centered on ILK, extracellular signal-
related kinase 1/2 (ERK1/2) and PI3K/Akt. In parallel, ALL
cells became resistant to chemotherapy-induced apoptosis
[90]. Formation of an hERG1/integrin/VEGF receptor com-
plex was previously observed in acute myeloid leukemia [19].
The possibility that interaction with CXCR4 also occurs in
these cells is matter for future studies.
Blocking hERG1 channels with specific drugs decreased
the protective effect conferred by MSCs to leukemic cells
function. Moreover, integrin activation depends on channel
activity. The channel role appears to be important for
both initiation of pro-survival signals and development of
drug resistance. Immunodeficient mice engrafted with ALL
cells and treated with channel blockers had increased rate
of leukemic cell apoptosis, reduced leukemic infiltration
and overall survival rates. What is more, hERG1 blockade
enhanced the therapeutic effect produced by corticosteroids.
4.5. MSCs and Nicotinic Receptors. Observations such as
the relatively recent one that smoking cessation in chronic
smokers produces a rapid increase of circulating endothelial
progenitor cells in peripheral blood led to suspect that the
tobacco products regulate MSC physiology [91]. In fact, it
was subsequently found that human MSCs express the entire
machinery for cholinergic signaling, namely, the synthesizing
enzyme choline acetyltransferase, the degrading enzyme
acetylcholinesterase, ACh itself, the nAChR subunits α3, α5,
and α7 and the muscarinic ACh receptor M2 [92]. Human
MSCs were also found to express β2 and β4 nAChR subunits
[93]. Nicotinic and muscarinic receptors are expressed
in different MSC populations [92], but stimulation with
receptors’ agonists leads to a rapid increase of intracellular
(Ca2+) in both [92, 93]. As in other cell types [47], this signal
converges onto ERK1/2 [92]. These results are consistent
with the general notion that nonneuronal tissues can express
the entire cholinergic machinery necessary to release ACh
for paracrine signaling. Tonic exposure to nicotinic ligands
in smokers alters proper regulation of such system. Interest-
ingly, α7 nAChRs were found to be implicated in the control
of MSC migration [93], in analogy with what was previously
observed in human keratinocytes [94]. The balance of the
nAChR effects on proliferation/apoptosis and migration is a
matter for future studies.
5. Conclusion
Knowledge about the cell physiology of ion channels and
transporters in stem cells is at an initial stage. Current
evidence indicates that, in analogy with what has been
observed in other cell types, stem cells, particularly the better
known human MSCs, express a wide variety of ion channels
which are implicated in different physiological functions.
Broadly speaking, certain classes of K+ channels cooperate
with Ca2+ and Cl− channels in regulating the calcium
transients and the volume oscillations that accompany the
cell cycle. Other K+ channel types control cell anchorage
with the stromal matrix and cell migration as well as release
of paracrine growth factors. The differential expression of
ion channel types in individual MSC cells indicates that
stem cell populations may be heterogeneous. One possibility
is that, as observed in other cell types, MSCs sampled at
different cell cycle phases present different channel activity or
expression (reviewed in [8]). Another possible explanation is
that MSC populations contain progenitor cells at different
stages of commitment, which would also affect the pattern of
ion channel expression and activity. Recent evidence in both
HSCs and MSCs indicates that ligand-gated channels, such
as nAChRs, also contribute to regulate stem cell biology.
From a therapeutic standpoint, MSCs have been lately
the object of intense interest. The perspectives these cells
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offer for clinical applications turn on their easy accessibility,
prompt expansibility, and capacity to differentiate. A more
thorough understanding of their physiological features,
including the details of how different ion channels and
transporters interplay, will be necessary for safer and reli-
able medical applications. Currently, four main therapeutic
approaches are being investigated: (i) local implantation of
MSC for focalized diseases, (ii) systemic transplantation,
(iii) combination of stem cell therapy with gene therapy,
and (iv) use of MSC in tissue repair and remodeling.
Considering the advantages offered by membrane channels
as targets of pharmacological therapy [95], we believe further
efforts along this line should suggest potentially fertile novel
methods to attempt therapy in both normal and cancer stem
cells.
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